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Abstract
We propose a mathematical model to investigate the effects of information–dependent vaccination
behavior on meningitis transmission. The information is represented by means of information index
as early proposed in (d’Onofrio et al., Theor. pop. biol., 2007). We perform a qualitative analysis
based on stability theory, focusing to the global stability of the disease free equilibrium (DFE) and
the related transcritical bifurcation taking place at the threshold for the DFE.
Finally, we assess the role of epidemiological and information parameters in the model dynamics
through numerical simulations. Our simulations suggests that the impact of the human behavior
critically depend on the average information delay. For example, it can induce recurrent epidemics,
provided that transfer rate from the carrier to the infectious state is over a threshold. Otherwise, the
endemic equilibrium is (at least) locally stable.
Keywords: Epidemic model, Meningitis, Vaccination, Information.
1 Introduction
Meningitis is an inflammation of the meninges, the protective membranes that surrounds the brain and
spinal cord. Meningitis is mainly caused by bacteria or viruses, although it may be rarely caused also by
fungi, parasites or free-living microscopic ameba [10]. Viral meningitis is more common than bacterial
meningitis but often less severe. This last can be deadly if not treated right away [10].
Meningococcal disease (MD) is a serious bacterial form caused by Neisseria meningitidis bacteria, which
has the potential to cause large epidemics. It can cause severe brain damage and is associated with high
fatality: it is fatal in 50% of cases if untreated. This form of meningitis is observed worldwide but the
highest burden of the disease is in the ‘meningitis belt’, an area of sub-Saharan Africa that stretches from
Senegal in the west to Ethiopia in the east, where around 30 000 cases are reported each year [43].
Neisseria meningitidis bacteria are transmitted from person-to-person through respiratory droplets or
throat secretions from carriers. The transmission of N. meningitidis is facilitated during mass gatherings
(as pilgrimages and jamborees) [43]. Most cases are acquired through exposure to asymptomatic carriers
and relatively few through direct contact with patients with MD [34].
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There are twelve different types of N. meningitidis, called serogroups, that have been identified. Only six
of them (A, B, C, W, X and Y) can cause epidemics [43]. The N. meningitidis serogroup A (NmA) is
the most commonly isolated pathogen in the African meningitis belt [21, 38, 44], where it has historically
accounted for 90% of MD cases and the majority of large-scale epidemics [10].
Mathematical modeling have the potential, and offer a promising way, to design effective prevention and
control strategies. An early approach to modeling the spread of meningitis is due to Pinner et al. in [32]
where the weekly attack rate (i.e. the number of individuals who get infected divided by the number of
people at risk for the infection) was estimated for both the vaccinated and non–vaccinated populations
during an epidemic of NmA in Nairobi, Kenya, in 1989.
The age structure of population has been often considered as an important modeling aspect in models
of meningococcal infection spread. Martcheva and Cornell [30] used an age-structured meningitis model
to identify the contribution of the carriers (infected who have the bacteria but appear healthy) to the
transmission of MD. Tuckwell et al. [39] proposed a discrete time model including age-dependent rates to
determine the impact of vaccination schedule on the time course of a meningococcal serogroup C (NmC)
disease in France. An age–structured model was developed by Trotter et al. [37] and then fitted to data on
immunization with NmC conjugate vaccines in England and Wales to investigate the effects of a conjugate
vaccine program. Deterministic compartmental models were fitted to age structured data sets of MD by
Coen et al. [12].
In recent years, mathematical models for MD based on the Susceptible–Carrier–Infectious–Recovered
(SCIR) structure have received much attention by scholars. Simpson and Roberts [35] used a SCIR model
to estimate the long–term effects of the 2004 vaccination campaign on the epidemic of meningococcal
B disease in New Zealand. A SCIR model developed by Irving, Blyuss and coworkers [4, 22] (where
they also developed some other SCIR-related models) suggested that temporary population immunity
is an important factor to include in models designed to attempt to predict meningitis epidemics and to
measure the efficiency of vaccines being deployed. G. Djatcha Yaleu et al. [15] considered vaccination in
a SCIR model for the dynamical transmission of NmA. They conclude that the control of the epidemic
of NmA pass through a combination of a large coverage vaccination of young susceptible individuals and
the production of a vaccine with a high level of efficacy. However, they used a set of parameters that are
highly unrealistic.
An important factor which has not been included in meningitis models, as far as we know, is the change
of social behavior of individuals as consequence of information and rumors on the spread of the disease
within their community [29, 42]. This phenomenon is a key factor regulating the propensity of individuals
in adopting non–mandatory protective measures. Well known examples are the vaccination for childhood
diseases like measles, mumps and rubella [42] and bed–nets for mosquito–borne diseases [3]. Also in
the case of meningitis, there is evidence that the perceptions of individuals about the disease affect
their decisions regarding therapeutic and preventive interventions [13]. This, in turn, influence disease
occurrence, morbidity and mortality. Specific studies regarding vaccination against Meningococcal C
revealed that parents’ perceived vulnerability and perceived control in preventing the infection seem to
influence parents’ evaluation of the vaccination programme. Therefore, these perceptions may, in principle,
affect vaccination behavior and could be relevant to be taken into account when educating population
about vaccination [36]. Another interesting investigation is the recent study focused on evaluating the
knowledge and attitudes about Meningococcal B and the relative vaccine for children among a sample of
parents in Italy [31] (see also a similar survey in Poland [19]). One of the conclusions, only apparently
trivial, was that people who knew that the vaccine was a preventive measure of meningitis were more
likely to have a positive attitude towards vaccination. On the other hand, in spite of the great successes
obtained by immunization programmes (as the long-term strategies in the African meningitis belt with
2
vaccine MenAfriVac R© against NmA meningitis [27]) vaccine hesitancy threatens to erode these gains
[14, 27] and push health policy makers to plan specific interventions [11].
The feedbacks of human behavior on the transmission and control of infections is the main focus of the
recently emerging research field of behavioral epidemiology (BE) of infectious diseases [29, 42]. Indeed, in
classical epidemic models [1, 8] individuals are modeled as passive particles randomly interacting according
to the mass-action principle of statistical physics [42], as they were reacting molecules of chemistry. This
paradigm does not account the role of human decisions in influencing the spread and the control of
infectious diseases, which are instead explicitly modeled in the framework of BE [41].
Vaccines for meningitis like MenAfriVac are given in mass for ages usually between 1 and 29 [26, 33]. A
possible way to modeling behavior–dependent vaccination at all ages relies on adopting the information–
based approach, which focuses on the case where the driving force of the vaccine demand is represented
by the time changes in the perceived risk of infection. This approach has been introduced in [16, 17] by
mean of a phenomenological model where the vaccination rates of newborn is an increasing function of
the information acquired on the spread of the infectious disease. Main applications concerned vaccines
targeted at childhood infectious diseases such as measles, mumps and pertussis [5, 6, 16, 17, 29, 42]. Only
few applications, as far as we know, concern with the case of vaccination at all ages [6, 7, 17, 25].
In this paper, motivated by the SCIR model developed in [22] and its variants [15, 35], we propose a BCM
mathematical model of meningitis transmission, including information–dependent vaccination at all ages.
The main aim is to theoretically assess, through the proposed model, how the information may affect the
dynamics of meningitis transmission within a given population. We will make use of analytical methods
for dynamical systems, like stability and bifurcation theory. The theoretical evaluation of the effects of
human decision on the disease control will be complemented by means of numerical simulations.
The paper is organized as follows: The model is presented in Section 2. In Section 3, the basic properties
of the model are given as well as the determination of the basic reproduction number. We also show that
an endemic equilibrium is possible and it is unique. In Section 4 we provide a stability analysis of the
disease free equilibrium and show, through bifurcation analysis, that the endemic equilibrium is stable, at
least when the basic reproduction number is close to its critical value. In Section 5 numerical simulations
are illustrated. Conclusions are given in Section 6.
2 The model
We assume that a given population may be divided into five distinct compartments: the susceptible
individuals (S), who are susceptible to infection; the vaccinated individuals (V ); the carriers (C), who
are carrying the infection and are infectious, but show no signs of the invasive disease; the infectious (I),
who have been infected by the disease and become immediately infectious; the recovered individuals (R).
The total population is denoted by N . Therefore, at time t it is
N(t) = S(t) + V (t) + C(t) + I(t) +R(t).
Individuals are assumed to be recruited into the population at a constant rate Λ. A mass vaccination for
all susceptible individuals is given with rate ν, so that νS individuals are transferred to the vaccinated
group V . We assume that vaccination is lifelong and does not have a waning effect.
After making an effective contact with carriers or infectious, the susceptible individuals become carriers.
The force of infection [8] of the disease, denoted as λ, will be described later. Carriers becomes infectious
at a rate σ and recover at a rate δ. Infectious individuals recover at a rate ρ. The model takes into
account both the natural death rate µ and disease-induced mortality rate d. Recovery from the disease is
not permanent, so we assume that the recovered individuals become susceptible again at rate φ.
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Therefore, the baseline model is governed by the following system of non linear ordinary differential
equations:
S˙ = Λ− λ(N)S − νS + φR− µS
V˙ = νS − µV
C˙ = λ(N)S − (σ + δ + µ)C
I˙ = σC − (ρ+ µ+ d)I
R˙ = δC + ρI − (φ+ µ)R,
(1)
where the upper dots denote the time derivatives. As for the force of infection λ(N), due to the asymp-
tomatic nature of carriers, their contact rate is supposed to be greater than that of infectious, which are
subject to identification and hospitalization. Therefore the level of infectiousness of C is greater than I,
say, by  > 1 factor [2]. As a consequence, the force of infection is given by
λ(N) = β
C + I
N
, (2)
where  ≥ 1, and β is the transmission rate of infectious.
Note that if d = 0 (and, of course, in absence of the disease) then the steady state value of the population
is N˜ = Λ/µ, since the dynamics of N(t) is ruled by
N˙ = Λ− µN. (3)
Now, we will build a behavioral variant of model (1) by introducing an information–dependent vaccination.
Following the approach of information-dependent models [16, 42] we assume that the vaccination rate ν is
an increasing function of an information index M , which summarizes the information about the current
and past values of the disease [16, 42]:
M(t) =
∫ t
−∞
g(C(τ), I(τ))Ka(t− τ)dτ. (4)
Here the function g describes the role played by the infectious size in the information dynamics and is
assumed to be dependent on the prevalence, i.e. on the compartments C and I (the basic properties of
g will be specified later). The term Ka is the delay kernel function, which represents the weight given to
past prevalence. The information variableM is described by a distributed delay for two main reasons. On
one hand, people may have memory of past epidemics: indeed vaccine–related decision seldom depends
on the current state of the spread of the disease. On the other hand, a delay in people awareness may be
consequence of the time-consuming routine procedures (like clinical tests, notification of cases, reporting
delays to public health authorities, etc.) that precede the dissemination of information on the disease’s
status in the community.
Combining (1) and (4), model (1) is modified in the following nonlinear integro–differential system :
S˙ = Λ− λ(N)S − ν(M)S + φR− µS
V˙ = ν(M)S − µV
C˙ = λ(N)S − (σ + δ + µ)C
I˙ = σC − (ρ+ µ+ d)I
R˙ = δC + ρI − (φ+ µ)R
M(t) =
∫ t
−∞ g(C(τ), I(τ))Ka(t− τ)dτ,
(5)
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where λ(N) is given in (2) and the function ν(M) models the information-dependent rate of vaccinations,
and it may be split as follows:
ν(M) = ν0 + ν1(M), (6)
where ν0 is a positive constant representing the fraction of susceptibles that are vaccinated independently
on the available current and historical information on the prevalence level of the disease and ν1(M) models
the fraction of susceptibles that are vaccinated depending on the social alarm caused by the disease [16].
The following basic assumptions are done regarding the functions g(C, I) and ν1(M): (i) g(C, I) and
ν1 are continuous and differentiable, except in some cases, at finite number of points; (ii) g(0, 0) = 0,
and ν1(0) = 0; (iii) g(C, I) and ν1 are positive for any positive value of their respective arguments; (iv)
0 < ∂g/∂C < c1, 0 < ∂g/∂I < c2, and 0 < ν′1(M) < c3, for some constants c1, c2 and c3.
The simplest specific functional form of ν1(M) is the linear function,
ν1(M) = bM, (7)
where b is a positive constant. Moreover, since the possibility of getting information from carriers group
C is almost not possible, we take g as a function of only the infected groups I. Again, the simplest form
is:
g(I) = h
I
N˜
= kI. (8)
Note that the size of the infectious compartment is normalized by divinding I by the reference steady
state population. In this case, the positive constant parameter h can be interpreted as the information
coverage. This may be seen as a ‘summary’ of two contrasting phenomena: the phenomenon of disease
under–reporting and the level of media and rumours coverage of the status of the disease, which tends to
amplify the social alarm [5].
As far as the kernel Ka(t) is concerned, a relevant example is the weak exponential delay kernel [28]
Ka(t) = a e
−at, (9)
where the parameter a assumes the biological meaning of inverse of the average delay of the collected
information on the disease, as well as the average length of the historical memory concerning the disease
in study. The Kernel (9) is a particular case of Erlangian distribution. This choice has the advantage of
making the corresponding integro-differential system reducible into ordinary differential equations through
the linear chain trick [28]. Model (5)–(2)–(4), with choices (6), (7), (8) and (9), may be written:
S˙ = Λ− λ(N)S − (ν0 + bM)S + φR− µS
V˙ = (ν0 + bM)S − µV
C˙ = λ(N)S − (σ + δ + µ)C
I˙ = σC − (ρ+ µ+ d)I
R˙ = δC + ρI − (φ+ µ)R
M˙ = a (kI −M) ,
(10)
and will be the subject of the investigation in this paper. The parameters, their descriptions and the
baseline values are given in Table 1.
3 Basic properties
We begin by determining the biologically feasible set for model (10). The following proposition also implies
that the solutions of (10) are bounded, provided that the initial conditions are non negative.
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Parameter Description Value (range) Unit Source and comments
µ Per–capita natural mortality rate for all classes 0.027397 years−1 Life expectancy is 50 years [22]
N˜ Steady state Population 1000000 adim. Assumed
Λ Inflow rate of susceptible individuals 20000 years−1 = µN˜
β Transmission Rate 100 (50, 200) years−1 [22]
ρ Rate of recovery of infectious individuals 52 years−1 Disease duration ≈ 1 week [22]
d Disease–induced death rate 5.2 years−1 Mortality probability ≈ 0.1 [22]
σ Rate moving from carrier to infected 26 (0.1,52) years−1 [22]
δ Recovery rate of carriers 26 (0.1, 52) years−1 [22]
φ Rate of loss of immunity 1 (0.04, 2) years−1 [22]
ν0 behavior–independent vaccination rate 0.04 years−1 Assumed
T Average information delay [0, 120] days From no delay to 4 months about.
a Inverse of average information delay = 365.25/Tdeal years−1 Inverse of T in years−1
b Slope of vaccination rate w.r.t. information index M 2000 (1,∞) years−1 Assumed
h Information coverage 0.5 (0.1, 1) adim. Assumed
 Enhanced infectiousness of carriers 1.3 adim. Assumed
Table 1: Description and baseline values of the parameters of model (10).
Theorem 1. The set
Ω = {(S, V, C, I, R,M) ∈ R6+ : 0 ≤M ≤ kN˜, 0 ≤ N˜
µ
µ+ d
≤ S + V + C + I +R ≤ N˜}. (11)
is positively invariant and absorbing.
Proof. It suffices to note that adding the first five equations of (10), it follows
N˙ = Λ− µN − dI, (12)
so that from
Λ− (µ+ d)N ≤ N˙ ≤ Λ− µN
it follows
lim sup
t→∞
N(t) ≤ N˜ .
lim inf
t→∞ N(t) ≤
Λ
µ+ d
= N˜
µ
µ+ d
.
Then, the rest of the proof follows from standard arguments as in [5].
It is easy to check that model (10) admits the disease–free equilibrium (DFE), which represents the
scenario where there is no infection within the community, given by:
E0 = (S0, V0, 0, 0, 0, 0) , (13)
where
S0 =
Λ
µ+ ν0
; V0 =
ν0Λ
µ(µ+ ν0)
Our next step is to determine the basic reproduction number (BRN) R0 associated to model (10). To this
aim, we apply the next generation matrix method (NGM) [40]. According to the well–known procedure
[40], we identify (C, I) and (S, V,R) as the infected and uninfected classes, respectively. Then, we can
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write the matrix F for the new infection and the matrix V for the remaining transfer. More precisely,
the matrix F , where the entries represent the rates of new infections (i.e. the rate of appearance of new
infections in compartments C and I), here is a column vector, actually, given by:
F =
[
λS
0
]
=
[
β
N (C + I)S
0
]
.
The matrix V where the entries represent the rate of infections transferred (i.e. it incorporates the
remaining transitional terms, namely births, deaths, disease progression, and recovery in C and I), is also
a vector, here, given by:
V =
[
(σ + δ + µ)C
−σC + (ρ+ µ+ d)I
]
.
According to NGM, the BRN R0 is the greatest of the eigenvalues of the matrix FV −1, where F and V
are the matrices obtained by differentiating F and V with respect to C and I and then evaluated at the
DFE E0. In our case, we have:
F˜ =
[
βS(N−C−I)
N2
βS(N−C−I)
N2
0 0
]
, V˜ =
[
(σ + δ + µ) 0
−σ (ρ+ µ+ d)
]
,
and therefore,
F = F˜ (E0) =
[ βµ
µ+ν0
βµ
µ+ν0
0 0
]
, V = V˜ (E0) =
[
(σ + δ + µ) 0
−σ (ρ+ µ+ d)
]
.
It can be easily checked that
FV −1 =
[ βµ
(µ+ν0)(σ+δ+µ)
+ βµσ(µ+ν0)(σ+δ+µ)(ρ+µ+d)
βµ
(ρ+µ+d)
0 0
]
,
and hence the BRN is given by:
R0 = βµ
(µ+ ν0)(σ + δ + µ)
+
βµσ
(µ+ ν0)(σ + δ + µ)(ρ+ µ+ d)
. (14)
The existence and uniqueness of an endemic equilibrium, which represent a steady state prevalence of the
disease in the population, is given in the following proposition:
Proposition 1. Model (10) admits an unique endemic equilibrium for R0 > 1.
Proof. Let us denote the generic equilibrium (i.e. the vector solution with positive constant components)
as E∗ = (S∗, V ∗, C∗, I∗, R∗,M∗). From (10) it follows:
S∗ = (σ+δ+µ)(ρ+µ+d)σλ∗ I
∗, V ∗ = (ν0+bM
∗)S∗
µ =
(ν0+bkI
∗)(σ+δ+µ)(ρ+µ+d)
µσλ∗ I
∗,
C∗ = (ρ+µ+d)σ I
∗, R∗ = δ(ρ+µ+d)+σρσ(φ+µ) I
∗, M∗ = kI∗.
where
λ∗ = β
C∗ + I∗
N∗
,
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and I∗ is the positive solution of
b2I
∗2 + b1I∗ + b0 = 0, (15)
where
b2 = σbkd b3,
b1 = σd(ν0 + µ) b3 − Λσbk b3 + βµφ [δ (ρ+ µ+ d) + σρ] [ (ρ+ µ+ d) + σ]− b3βµ [ (ρ+ µ+ d) + σ] ,
b0 = σΛ(ν0 + µ) b3[R0 − 1],
and
b3 = (φ+ µ)(σ + δ + µ)(ρ+ µ+ d).
Let
f(I∗) = b2I∗2 + b1I∗ + b0. (16)
Note that f ′′(I∗) = b2 > 0, and f(0) = b0 > 0 for R0 > 1. Moreover, since N∗ > 0, from (12) it follows
I∗ < Λd , and direct calculations reveal that
f
(
Λ
d
)
= −βµΛ
d
[ (ρ+ µ+ d)σ]
{
µδρ+ µσρ+ (φ+ µ)µ [(ρ+ µ+ d) + σ] + δµ2 + µδd
}
< 0.
Therefore the function f has only one zero on
[
0, Λd
]
, implying that the endemic equilibrium is unique
provided that R0 > 1, whereas and no endemic equilibria are admissible for R0 < 1.
4 Stability of equilibria
We begin with the following local stability result:
Proposition 2. If R0 < 1 then E0 is locally asymptotically stable in Ω, and unstable if R0 > 1.
Proof. This result is a direct consequence of the NGM used in Section 3, see Theorem 2 in [40].
In epidemiological terms, Theorem 2 states that it is possible to control the epidemic if we can reduce the
value of R0 < 1 as long as the initial population is in the neighborhood of the DFE point E0. However,
it is not difficult to show that for R0 < 1 the elimination of the disease happens independently from the
initial size of the population. In other words, E0 is globally asymptotically stable (GAS) for R0 < 1. This
is stated in the following theorem.
Proposition 3. If R0 < 1, then E0 is globally asymptotically stable in Ω.
Proof. This result can be obtained by checking that all the (five) hypotheses of Theorem 4.3 in [23] are
satisfied. This procedure is well known and used elsewhere (see for example, Theorem 2 in the recent
paper [24]). For our model the result can be obtained in the same way. Therefore, for the sake of brevity,
we omit the details.
Remark. Note that in the reality,it is unlikely to have baseline vaccination rates sufficiently large to erad-
icate the disease. In other words the above theorem is equivalent to say that under voluntary information-
driven vaccination the eradication is impossible.
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As far as the stability of the endemic equilibrium E∗ is concerned, it is difficult to obtained an analytical
stability result, even through the linearization method. However, we can use a bifurcation theory approach
to get an insight on the stability properties of the model (and therefore of E∗) for values of the BRN close
to the critical value R0 = 1. We know that the DFE E0 is a nonhyperbolic equilibrium for R0 = 1 (this
follows because the Jacobian matrix of system (10), evaluated at E0, admits a zero eigenvalue) and we
also know from Proposition 1 that there is an endemic equilibrium branch bifurcating from E0 at R0 = 1.
What we are interested in is to check that such a branch is stable, at least when BRN is close to the
critical value R0 = 1 (in such case, the bifurcation is a transcritical forward bifurcation [9]). To this aim,
we study the centre manifold at the criticality (i.e. at E0 for R0 = 1) by using the approach developed in
[9, 20, 40], which establishes that the normal form representing the dynamics of the system on the centre
manifold is given by
y˙ = A1 φ y + A2 y
2,
where φ denotes a bifurcation parameter to be chosen, and
A1 = v ·Dxφf(x0, 0)u ≡
n∑
k,i,j=1
vkui
∂2fk(x0,0)
∂xi∂φ
. (17)
and,
A2 =
v
2 ·Dxxf(x0, 0)u2 ≡ 12
n∑
k,i,j=1
vkuiuj
∂2fk(x0,0)
∂xi∂xj
, (18)
where fk, k = 1, . . . , n denote the right hand sides of the system (10), x denotes the state vector, x0 the
disease free equilibrium E0 and v and u denote the left and right eigenvectors, respectively, corresponding
to the zero eigenvalue of the Jacobian matrix of system (10) evaluated at the criticality.
In our case, let us choose β as bifurcation parameter. Observe that R0 = 1 is equivalent to
β = β∗ :=
(µ+ ν0)(σ + δ + µ)(ρ+ µ+ d)
µ [(ρ+ µ+ d) + σ]
, (19)
so that the DFE E0 is (globally) stable when β < β∗, and is unstable when β > β∗. Therefore, β∗ is a
bifurcation value.
The direction of the bifurcation occurring at β = β∗ can be derived from the sign of coefficients (18) and
(17). More precisely, if A1 > 0 and A2 < 0, then at β1 = β∗ there is a forward bifurcation [9]
In our case we have the following:
Theorem 2. System (10) exhibits a forward bifurcation at E0 and R0 = 1.
Proof. The Jacobian matrix of system (10) evaluated at E0 and β = β∗ is given by:
Jβ∗ =

−(ν0 + µ) 0 − β
∗µ
ν0+µ
− β∗µν0+µ φ − bΛµ+ν0
ν0 −µ 0 0 0 bΛµ+ν0
0 0 β
∗µ
ν0+µ
− (σ + δ + µ) β∗µν0+µ 0 0
0 0 σ −(ρ+ µ+ d) 0 0
0 0 δ ρ −(φ+ µ) 0
0 0 0 ak 0 −a

(20)
The eigenvalues are λ1 = −(ν + µ), λ2 = −µ, λ3 = −(φ + µ), λ4 = −a, and two roots of the quadratic
equation:
ϕ2 +
[
β∗µ
ν0 + µ
− (σ + δ + µ)− (ρ+ µ+ d)
]
ϕ− β
∗µ
ν0 + µ
((ρ+ µ+ d) + σ) + (σ + δ + µ)(ρ+ µ+ d) = 0.
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From (19) it follows that
ϕ2 +
{
(σ + δ + µ)(ρ+ µ+ d)
(ρ+ µ+ d) + σ
− [(σ + δ + µ) + (ρ+ µ+ d)]
}
ϕ = 0.
Therefore, the remaining two eigenvalues are λ5 = 0, and
λ6 = − (σ + δ + µ)σ + (ρ+ µ+ d)((ρ+ µ+ d) + σ)
(ρ+ µ+ d) + σ
< 0.
Hence, the matrix Jβ∗ has zero as a simple eigenvalue and all the other eigenvalues are real and negative.
Now, we determine the right and left eigenvectors of Jβ∗ corresponding to the zero eigenvalue. Let
u = (u1, u2, u3, u4, u5, u6)
T denote a right eigenvector associated with the zero eigenvalue λ5 = 0, i.e.
Jβ∗u = 0.
After some algebraic manipulations, we get:
u1 =
β∗
(ν0 + µ)2
[
−µ(ρ+ µ+ d)
σ
− µ+ φ(ν0 + µ)[δ(ρ+ µ+ d) + σρ]
β∗σ(φ+ µ)
− bkΛ
β∗
]
u4,
u2 = [
ν0
µ
β∗
(ν0 + µ)2
[
−µ(ρ+ µ+ d)
σ
− µ+ φ(ν0 + µ)[δ(ρ+ µ+ d) + σρ]
β∗σ(φ+ µ)
− bkΛ
β∗
]
+
bkΛ
µ(µ+ ν0)
]u4,
u3 =
(ρ+ µ+ d)
σ
u4,
u4 = u4 ≥ 0,
u5 =
δ(ρ+ µ+ d) + σρ
σ(φ+ µ)
u4,
u6 = ku4.
Similarly, the left eigenvectors can be determined from equation vJβ∗ = λv, or equivalently JTβ∗v
T = 0,
and we get:
v1 = v2 = v5 = v6 = 0, v3 =
(ρ+ µ+ d)
σ
v4, v4 = v4 ≥ 0.
The coefficients (18) and (17) can now be computed. It follows that:
A1 = v3
[
µ
ν0 + µ
(u3 + u4)
]
,
and
A2 = −v3 β
∗µ
Λ(ν0 + µ)
[
bΛ
µ(ν0 + µ)
ku4 (u3µ+ ku4)u4µ+ 2u
2
3µ+ u3u4(+ 1)µ+ u3u5µ+ 2u
2
4µ+ u4u5µ
]
.
Therefore we have A1 > 0 and A2 < 0 and the system undergoes a forward bifurcation. In other words,
when R0 crosses the threshold value R0 = 1 from left to right, the disease free equilibrium changes its
stability from asymptotically stable to unstable and a positive endemic equilibrium E∗ appears and this
last is locally asymptotically stable, at least for values of R0 close to 1.
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Figure 1: Endemic equilibrium for I vs. normalized information coverage h. Solid black line: b = 1000,
dashed red line: b = 2000. Other parameters: as in the Table 1.
5 Numerical Investigations
In this section we will assess how the endemic equilibrium and the dynamics of the model depend on some
key behavioral and epidemiological parameters.
In Figure 1 we consider how the steady state number of infectious at the endemic equilibrium, I∗, depends
on the normalized information coverage h (whose range is (0, 1)) for the following values of the sensitivity
slope: b = 1000 (black solid line), and b = 2000 (red dashed line). Not surprisingly, I∗ is decreasing with
increasing both h and b.
As far as the simulations of the spread and control of the disease are concerned, we will consider the
following initial conditions:
i) before the introduction of the disease the population was at its steady state, thus N(0−) = N˜ ;
ii) one single infectious subject enters into the population: I(0) = 1;
iii) No carriers and removed subjects are present at t = 0: C(0) = 0 and R(0) = 0;
iv) a relatively small fraction of the population has been vaccinated: V (0) = 0.1N˜ . It follows that
S(0) = 0.9N˜ − 1.
We first consider the epidemic scenario, by simulating the system from the initial time to one year later
(t ∈ [0, 1]) as illustrated in Figure 2 and Figure 3. Namely, in the left panel of Figure 2 we show the
time–course of both C and I in the case where there is no behavioral dependence of the vaccination rate,
i.e. b = 0, which implies that ν(M) = ν0. In both the central and right panels of Figure 2, where we set
b = 2000, we show the cases corresponding to T = 10 days and T = 120 days, respectively. For T = 10
we can see that the prompt response induces a remarkable decrease of the epidemic peak, which is no
more observed for T = 120 days. The time course of the total population N(t) during the first year is
shown in Figure 3.
An analytical assessment of the onset of bifurcations is hard to obtain. Thus, given the parameter a, we
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Figure 2: Impact of behavioral terms on the epidemics outbreak during the first year. Time courses of
C(t) (red) and of I(t) (black). Left panel: absence of behavioral components in the vaccination (b = 0);
central and left panel: presence of behavioral components in the vaccination (b = 1000). Central panel:
T = 10 days; right panel: T = 120 days. In all panels σ = 26. Other parameters as in the Table 1
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Figure 3: Impact of behavioral terms on the total population N(t) during the epidemics outbreak. Left
panel: absence of behavioral components in the vaccination (b = 0); central and left panel: presence of
behavioral components in the vaccination (b = 1000). Central panel: T = 10 days; right panel: T = 120
days. In all panels σ = 26. Other parameters as in the Table 1.
computed the eigenvalues λi(a). The maximum value of the real part of the λi(1/T ) is then plotted in
Figure 4 (left panel). As it can be seen, there is an interval T ∈ (Tmin, Tmax) ≈ (24, 1645) days where the
endemic equilibrium is unstable and steady state oscillations (not necessarily periodic) can take place. In
other words, the model predict the onset of recurrent epidemics. Note that for T ≈ 220 days the largest
positive real part of the eigenvalues reaches its maximum. In Figure 5 we plotted the corresponding steady
state oscillations for, respectively, T = 120 days (left panel) and for T = 220 days (right panel). As one
can see the model predicts recurrent epidemics. Observe that for T = 220 days the epidemics have larger
peak and period than for T = 120 days.
All the above simulations were performed by assuming δ ≈ σ (see Table 1), i.e. the recovery rate of carriers
is equal to the rate of moving from carriers to infected, which seems reasonable. This however cause a
large infectious peak, as in the models considered by Irving et al. [22], where - however - vaccination
was not considered. The presence of vaccination and of behavior–dependent increase of the vaccination
rate, of course, partially mitigate this phenomenon. Irving and coauthors noticed in [22] that in their
model lower peaks of I(t) are obtained by assuming δ >> σ. Since PR = δ/(δ + σ) is the probability
that an individual going out of the C compartment enters in the R compartment, the above–mentioned
hypotheses is equivalent to assume that pR ≈ 1, i.e. that the vast majority of carriers do not become
infectious. To compare, the assumption δ = σ correspond to pR = 0.5, i.e. that half of carriers become
infectious (apart those dying for natural causes, of course).
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Figure 4: Bifurcation diagrams at the endemic equilibrium. Left panel: one bifurcation parameter, T ,
and σ = 26. Right panel: two bifurcation parameters: (T, σ). Other parameters as indicated in the Table
1. The region of instability is in light color, and the local stability region is dark.
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Figure 5: Steady state oscillations. Left panel: T = 120days; right panel: T = 220days. Red lines: C(t),
black lines: I(t). Other parameters as in Table 1.
Based on the above considerations, we computed a two-parameters bifurcation diagram (BBD) where not
only T but also σ is considered as bifurcation parameter. The BBD is shown in Figure 4 (right panel),
where the region of instability is in light color, and the local stability region is dark. Our numerical
computations showed that: i) under a threshold value σ = σm ≈ 4.9 the system is LAS; ii) for σ ∈ (σm, 26)
the endemic equilibrium is unstable in a window of values of T : T ∈ (Tmin(σ), Tmax(σ)) whose size
A = Tmax(σ)− Tmin(σ) increases with σ.
To show the impact of σ in the first phase of epidemics, we performed alternative simulations by setting
a lower value of pR compared to pR = 0.5. Namely we set δ = 10σ, which implies that pR = 1/9.
The simulation is reported in Figure 6, where one can observe that the epidemic peak is reduced when
compared to the case shown in Figure 2.
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Figure 6: Simulations of the first year of the spread of the disease, with σ = 2.6years−1. Left panel:
T = 10days, right panel: T = 120days. Other parameters as in Table 1.
6 Conclusions
As far as we know, the effects of information-dependent behavior on meningitis transmission has not
been studied before in the context of behavioral epidemiology [29]. Here, we propose a variant of a well
established meningitis model, where an information–dependent vaccination behavior is explicitly taken
into account. This is done by considering the information index as early proposed in [16].
The qualitative analysis of the resulting behavioral change model is based on stability and bifurcation
theory. These results extend (in some way) the ones obtained in [4, 22, 15], in that: i) we included
behavioral effects; ii) we get a rigorous results concerning the transcritical bifurcation taking place at the
threshold R0 = 1.
The BRN of the model does not depend on the information-related parameters, thus the GAS result
concerning the DFE can be read (similarly to the case of the SIR model with behavioral vaccination in-
vestigated in [16]) as an eradication impossible result [29, 42]. Indeed, to guarantee the disease eradication
the baseline behavior–independent vaccination rate ought to be as great as to guarantee the eradication
in absence of the behavioral effects in the vaccination rate. This is, of course, unlikely [29, 42].
As far as the information effects are concerned, our simulations suggests that, of course, it contributes
to reduce the epidemic peak. However, this holds in the case where T is medium–small. At the endemic
state, the equilibrium size of the compartment of infectious I∗ is a decreasing function of the information
coverage and of b.
The delay T is able to destabilize the endemic equilibrium by inducing steady state recurrent epidemics.
For σ = 26 we found that the destabilization is observed for a windows of values of T .
Irving and coworkers [22] stressed that the parameter σ, which is the rate of the transfer from the carrier
to the infectious state, has major impact in absence of vaccination. We found that σ remains of major
relevance also in presence of behavior-dependent vaccinations, with specific effects. It does not only deeply
modify the epidemic outbreaks (by reducing the peak of I and increasing that of C), as it is intuitive since
it rules how many carriers do become infectious, but it also significantly impact on the onset of recurrent
epidemics. Indeed, our numerical analysis suggest that there is a critical value σm such that for σ < σm
no oscillatory solutions occur, and the size of the above–mentioned ‘instability window’ for T increases
with σ. In other words, there is a nonlinear interplay between the epidemics-related parameter σ and the
behaviour–related parameter T .
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This study is very preliminary and specific assumptions have been made to make model (5) more tractable.
Furthermore, the obtained qualitative results need to be validated by field data, especially as far as the
behavioral aspects are concerned. Future investigations will mainly concern three areas: i) the possible
interplay between the important seasonal changes of β and also of σ stressed in [22] with the behavioral
components we introduced here; ii) the effect of more realistic non–Erlangian kernels (as the acquisition–
fading kernel introduced in [18]); iii) the optimal control of public health strategies aimed at increasing
vaccine acceptance.
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